Abstract
In this study, the therapeutic effect of Mel-incubated Adipose-derived mesenchymal stem cells (ADSCs) on CCl4-induced hepatic fibrosis was investigated. Mice with hepatic fibrosis were intraperitoneally injected with 8% CCl4 twice a week for 4 weeks. Starting from week 5, mice in the ADSC group and ADSC + Mel group were injected with 1 mL PBS cell suspension containing 1 × 106 ADSCs or ADSCs pretreated with 50 nM Mel twice a week for 2 consecutive weeks. Results: In the model group, severe histopathological changes were observed in the liver, including severe vacuolation, nuclear fragmentation, and liver fibrosis, and these changes were ameliorated by Mel-pretreated ADSCs. RT-qPCR results showed that Mel-induced ADSCs significantly inhibited the expression of proapoptotic genes (Caspase-8, Bax, and Caspase-3) and promoted the expression of an anti-apoptotic gene (Bcl-2). Immunohistochemical results showed that a large number of MMP-9-, TGF-β-, and MMP-2-positive cells were present in the liver tissues of the model group, while the number of positive cells was reduced by Mel-induced ADSCs. ELISA results showed that the ADSC pretreated with Mel also significantly reduced the expression levels of TNF-α and IL-6. Conclusion: ADSCs pretreated with Mel significantly improved CCl4-induced liver fibrosis.
Acknowledgements
Not Applicable.
Ethics approval and Consent to participate
All animal care and experimental protocols were conducted according to the University Policies on the Use and Care of Animals and were approved by the Institutional Animal Experiment Committee of Henan University of Science and Technology, China (Animal License Number: ZHXK20190020).
Author contributions
HJ Wang, YX Yang, RQ Dong, YL Xu, MY Zhang performed the experiments. QX Lv and XG Chen analyzed the data. YY Sun and HJ Wang prepared the manuscript. YM Liu and YY Sun revised the manuscript. ZQ Zhang and YM Liu proposed the concept of the study and directed the design and implementation of the study.
Disclosure statements
The authors declare that they have no competing interests or declarations.
Consent to publish
Not applicable.
Data availability statement
The data underlying this article will be shared by the corresponding author upon reasonable request.